Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 18,433 |
|
|||||
| News | - | ||||||
| Day High | 1.17 | Low High |
|||||
| Day Low | 1.14 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Co Diagnostics Inc | CODX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -0.86% | 1.15 | 17:59:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.14 | 1.14 | 1.17 | 1.15 | 1.16 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 137 | 18,433 | $ 1.16 | $ 21,353 | - | 0.975 - 1.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:58:48 | 30 | $ 1.15 | USD |
Co Diagnostics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 35.95M | 31.26M | - | 6.81M | -36.41M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Co Diagnostics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CODX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.24 | 1.2499 | 1.091 | 1.17 | 74,682 | -0.09 | -7.26% |
| 1 Month | 1.17 | 1.29 | 1.0689 | 1.17 | 69,038 | -0.02 | -1.71% |
| 3 Months | 1.27 | 1.33 | 1.02 | 1.16 | 58,904 | -0.12 | -9.45% |
| 6 Months | 1.07 | 1.6567 | 1.02 | 1.26 | 84,767 | 0.08 | 7.48% |
| 1 Year | 1.52 | 1.89 | 0.975 | 1.28 | 93,505 | -0.37 | -24.34% |
| 3 Years | 8.90 | 11.82 | 0.975 | 7.10 | 393,651 | -7.75 | -87.08% |
| 5 Years | 1.00 | 31.40 | 0.694 | 11.11 | 1,609,701 | 0.15 | 15.00% |
Co Diagnostics Description
| Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests. |
